In addition, attention should also be paid to the effect of GLP-1 at different sites of administration and blood concentrations
This is mainly because of the reported weight loss While GLP-1 medications Zepbound and This rapid increase in users of GLP-1 drugs has caused Now, a new study published in Annals of Internal Medicine , reports that among the approximately 1 million new GLP-1 medication users identified between 2011 to 2023, there was a twofold increase in GLP-1 medication users who do not have type 2 diabetes but do have a body mass index (BMI) of 30 killograms per square meter (kg/m 2 ) or greater, and in people with a BMI of 27 to 30 kg/m 2 and an obesity-related The researchers also found that the proportion of users of GLP-1 medications without FDA-approved indications rose from 0.21% in 2019 to 0.37% in 2023
In-Depth Analysis of GLP-1 Nutritional Support Market in India The CAGR value moved up from nearly 11.3% in 2020 to 2024 to 16.8% for 2025 to 2035, supported by growth in private metabolic clinics and broader primary care integration
Vitamin B12 is vital for maintaining healthy nerves and blood cells, but the body cannot produce it on its own
"Its a smart sales strategy, but Im not sure its a very good strategy for thinking about the health of people who are interested in taking these drugs and who could benefit from them," Dusetzina told NBC News
Quality Control : Unlike FDA-approved medications, compounded drugs dont undergo the same rigorous testing for purity, potency, and sterility